Location: New York, New York
Academic / Research
The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world's most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years.
In compliance with applicable State regulatory authorities, COVID-19 vaccination is mandatory for all MSK staff. Staff are considered fully vaccinated upon completion of a primary vaccination series for COVID-19 (i.e., one dose of a single dose vaccine or a final dose of a multi-dose vaccine series). Exceptions from the COVID-19 vaccine requirement are permitted for those who request and receive an approved medical or fully remote exemption. Requests for medical exemption can take up to two weeks to review. Vaccination or an approved medical exemption is required to start work.
*Staff working at a MSK New Jersey location must be up to date with COVID-19 vaccination, which includes having completed the primary COVID-19 vaccination series and booster once eligible as mandated by New Jersey State. All New Jersey staff not yet eligible for a booster must receive a booster within 3 weeks of becoming eligible as a condition of continued employment at MSK.
Note: Individuals are eligible to receive a COVID-19 booster two months after completion of a primary vaccination series for COVID-19. Because vaccine-induced immunity can wane over time, MSK continues to strongly urge all staff to get a COVID-19 booster as soon as they become eligible to maintain their protective immunity for a longer period.
We are seeking a highly motivated postdoctoral fellow in biostatistics who is interested in statistical andcomputational methods development and application. This position will provide exciting opportunities to workwith large-scale multi-center telehealth data and develop novel methods for causal inference, machine learning,data integration, and precision oncology. Successful candidate will work on development, as well as applicationsof these methods and will participate in knowledge generation and will be expected to publish findings in toptier statistical and biomedical literature.
This position will be supported by MATCHES (Making TelehealthDelivery of Cancer Care at Home Effective and Safe), a new NCI-funded center(https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-21-029.html) dedicated to building the necessaryevidence base to guide the appropriate role of telehealth in the delivery of cancer care. A multi-disciplinary teamof investigators at MSK has received a 5-year award to support this work and will launch this project in the fallof 2022.
Applicants should hold a Ph.D. degree in biostatistics, statistics, machine learning, or a related field. Thesuccessful candidate should have solid methodological training in statistics, be comfortable working with largedata sets, be proficient in R and/or Python, and have experience working on Unix/Linux systems. Priorexperience with telehealth data, causal inference, and precision medicine would be an asset.The successful applicant will be supervised jointly by Drs. Yuan Chen, Katherine Panageas, and Mithat Gonen.This position is open immediately. The initial appointment is for two years with a possibility for renewal. Toapply, please send a cover letter, CV, research statement (optional) and the names of 3 references by email toSamantha Vasquez at email@example.com.
MSKCC is an equal opportunity and affirmative action employer committed to diversity and inclusion in allaspects of recruiting and employment. All qualified individuals are encouraged to apply and will receiveconsideration without regard to race, color, gender, gender identity or expression, sexual orientation, nationalorigin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basisfor an employment decision.